{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T21:59:14Z","timestamp":1774907954640,"version":"3.50.1"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,1,2]]},"DOI":"10.18632\/oncotarget.23142","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T18:49:38Z","timestamp":1513104578000},"page":"743-754","source":"Crossref","is-referenced-by-count":16,"title":["Organic cation transporter 3 mediates cisplatin and copper cross-resistance in hepatoma cells"],"prefix":"10.18632","volume":"9","author":[{"given":"Sarah","family":"Guttmann","sequence":"first","affiliation":[{"name":"Medizinische Klinik B f\u00fcr Gastroenterologie und Hepatologie, Universit\u00e4tsklinikum M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gursimran","family":"Chandhok","sequence":"additional","affiliation":[{"name":"Medizinische Klinik B f\u00fcr Gastroenterologie und Hepatologie, Universit\u00e4tsklinikum M\u00fcnster, M\u00fcnster, Germany"},{"name":"Present address: Monash Biomedicine Discovery Institute, and Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Reinartz","family":"Groba","sequence":"additional","affiliation":[{"name":"Medizinische Klinik B f\u00fcr Gastroenterologie und Hepatologie, Universit\u00e4tsklinikum M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Niemietz","sequence":"additional","affiliation":[{"name":"Medizinische Klinik B f\u00fcr Gastroenterologie und Hepatologie, Universit\u00e4tsklinikum M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Sauer","sequence":"additional","affiliation":[{"name":"Medizinische Klinik B f\u00fcr Gastroenterologie und Hepatologie, Universit\u00e4tsklinikum M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Gomes","sequence":"additional","affiliation":[{"name":"Medizinische Klinik B f\u00fcr Gastroenterologie und Hepatologie, Universit\u00e4tsklinikum M\u00fcnster, M\u00fcnster, Germany"},{"name":"Present address: Wilson Disease Clinic, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliano","family":"Ciarimboli","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinikum M\u00fcnster, Medizinische Klinik D, Experimentelle Nephrologie, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Karst","sequence":"additional","affiliation":[{"name":"Institute of Inorganic and Analytical Chemistry, University of M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andree","family":"Zibert","sequence":"additional","affiliation":[{"name":"Medizinische Klinik B f\u00fcr Gastroenterologie und Hepatologie, Universit\u00e4tsklinikum M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut H.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Medizinische Klinik B f\u00fcr Gastroenterologie und Hepatologie, Universit\u00e4tsklinikum M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,12,12]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/annonc\/mdu155","article-title":"Hepatic arterial infusion chemotherapy with cisplatin before radical local treatment of early hepatocellular carcinoma (JIS score 0\/1) improves survival","volume":"25","author":"Yoshida","year":"2014","journal-title":"Ann Oncol"},{"key":"3","first-page":"862","article-title":"A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma","volume":"52","author":"Maehara","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"4","doi-asserted-by":"crossref","first-page":"e1257","DOI":"10.1038\/cddis.2013.428","article-title":"Systems biology of cisplatin resistance: past, present and future","volume":"5","author":"Kroemer","year":"2014","journal-title":"Cell Death Dis"},{"key":"5","first-page":"547","article-title":"Membrane transporters as mediators of cisplatin side-effects","volume":"34","author":"Ciarimboli","year":"2014","journal-title":"Anticancer Res"},{"key":"6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-642-14541-4_3","article-title":"Organic cation transporters (OCTs, MATEs),andevidence for the importance in drug therapy","volume":"201","author":"Schwab","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"7","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2353\/ajpath.2010.090610","article-title":"Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions","volume":"176","author":"Schlatter","year":"2010","journal-title":"Am J Pathol"},{"key":"8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bcp.2007.03.004","article-title":"Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity","volume":"74","author":"Inui","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"9","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1124\/mol.106.022624","article-title":"Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin","volume":"70","author":"Howell","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1158\/0008-5472.CAN-12-0888","article-title":"Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy","volume":"72","author":"Chen","year":"2012","journal-title":"Cancer Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1126\/science.3175622","article-title":"Overexpression of metallothionein confers resistance to anticancer drugs","volume":"241","author":"Lazo","year":"1988","journal-title":"Science"},{"key":"12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1139\/O10-150","article-title":"Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B","volume":"89","author":"Dmitriev","year":"2011","journal-title":"Biochem Cell Biol"},{"key":"13","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1158\/1078-0432.CCR-04-0137","article-title":"Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells","volume":"10","author":"Howell","year":"2004","journal-title":"Clin Cancer Res"},{"key":"14","first-page":"1312","article-title":"Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance","volume":"60","author":"Akiyama","year":"2000","journal-title":"Cancer Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1158\/1078-0432.CCR-03-0689","article-title":"Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cells","volume":"10","author":"Howell","year":"2004","journal-title":"Clin Cancer Res"},{"key":"16","first-page":"987","article-title":"Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines","volume":"18","author":"Yamamoto","year":"2007","journal-title":"Oncol Rep"},{"key":"17","doi-asserted-by":"publisher","first-page":"22779","DOI":"10.18632\/oncotarget.8059","article-title":"ATP7B expression confers multidrug resistance through drug sequestration","volume":"7","author":"Furukawa","year":"2016","journal-title":"Oncotarget"},{"key":"18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccr.2010.04.011","article-title":"Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator","volume":"17","author":"Hanahan","year":"2010","journal-title":"Cancer Cell"},{"key":"19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1039\/C6MT00176A","article-title":"Copper trafficking to the secretory pathway","volume":"8","author":"Lutsenko","year":"2016","journal-title":"Metallomics"},{"key":"20","doi-asserted-by":"crossref","first-page":"e98809","DOI":"10.1371\/journal.pone.0098809","article-title":"The effect of zinc and D-penicillamine in a stable human hepatoma ATP7B knockout cell line","volume":"9","author":"Schmidt","year":"2014","journal-title":"PLoS One"},{"key":"21","doi-asserted-by":"crossref","first-page":"7793","DOI":"10.1074\/jbc.M805145200","article-title":"Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug","volume":"284","author":"Huster","year":"2009","journal-title":"J Biol Chem"},{"key":"22","doi-asserted-by":"crossref","first-page":"F44","DOI":"10.1152\/ajprenal.00593.2007","article-title":"Cytoplasmic initiation of cisplatin cytotoxicity","volume":"295","author":"Price","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00424-013-1335-8","article-title":"The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3","volume":"466","author":"Ciarimboli","year":"2014","journal-title":"Pflugers Arch"},{"key":"24","first-page":"6559","article-title":"Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper","volume":"62","author":"Howell","year":"2002","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.23103","article-title":"Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver","volume":"50","author":"Schaeffeler","year":"2009","journal-title":"Hepatology"},{"key":"26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1124\/mol.64.2.466","article-title":"The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells","volume":"64","author":"Howell","year":"2003","journal-title":"Mol Pharmacol"},{"key":"27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1124\/mol.66.1.25","article-title":"Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B","volume":"66","author":"Howell","year":"2004","journal-title":"Mol Pharmacol"},{"key":"28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ygyno.2004.12.042","article-title":"Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a prognostic factor in human endometrial carcinoma","volume":"97","author":"Yaegashi","year":"2005","journal-title":"Gynecol Oncol"},{"key":"29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/ijc.10608","article-title":"Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP","volume":"101","author":"Takebayashi","year":"2002","journal-title":"Int J Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/ijc.24273","article-title":"Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy","volume":"124","author":"Abad","year":"2009","journal-title":"Int J Cancer"},{"key":"31","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0002-9440(10)61234-5","article-title":"Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2","volume":"167","author":"Schlatter","year":"2005","journal-title":"Am J Pathol"},{"key":"32","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1158\/0008-5472.CAN-06-0769","article-title":"Organic cation transporters are determinants of oxaliplatin cytotoxicity","volume":"66","author":"Giacomini","year":"2006","journal-title":"Cancer Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1158\/1535-7163.MCT-09-1084","article-title":"Organic cation transporters modulate the uptake and cytotoxicity of picoplatin, a third-generation platinum analogue","volume":"9","author":"Giacomini","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"34","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1124\/dmd.108.023168","article-title":"Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer","volume":"36","author":"Inui","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1124\/jpet.106.110346","article-title":"Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family)","volume":"319","author":"Inui","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00280-007-0640-3","article-title":"Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines","volume":"62","author":"Yokoyama","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"37","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jps.22752","article-title":"Contribution of organic cation transporter 3 to cisplatin cytotoxicity in human cervical cancer cells","volume":"101","author":"Shu","year":"2012","journal-title":"J Pharm Sci"},{"key":"38","first-page":"443","article-title":"Cross-resistance of platinum derivatives in H-1R, a cisplatin-resistant cell line","volume":"21","author":"Fujita","year":"2009","journal-title":"Oncol Rep"},{"key":"39","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1080\/00498250701882482","article-title":"Organic cation transporters","volume":"38","author":"Ciarimboli","year":"2008","journal-title":"Xenobiotica"},{"key":"40","doi-asserted-by":"publisher","first-page":"74348","DOI":"10.18632\/oncotarget.20637","article-title":"Upregulated SLC22A3 has a potential for improving survival of patients with head and neck squamous cell carcinoma receiving cisplatin treatment","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2407-12-109","article-title":"Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance","volume":"12","author":"Schuchmann","year":"2012","journal-title":"BMC Cancer"},{"key":"42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00280-003-0736-3","article-title":"Cross-resistance to cisplatin in cells with acquired resistance to copper","volume":"53","author":"Howell","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"key":"43","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1158\/1535-7163.1543.3.12","article-title":"Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells","volume":"3","author":"Kuo","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"44","doi-asserted-by":"crossref","first-page":"G356","DOI":"10.1152\/ajpgi.90632.2008","article-title":"Deletion of hepatic Ctr1 reveals its function in copper acquisition and compensatory mechanisms for copper homeostasis","volume":"296","author":"Lee","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"45","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1039\/C6MT00076B","article-title":"Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity","volume":"8","author":"Howell","year":"2016","journal-title":"Metallomics"},{"key":"46","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1517\/14728222.2015.1043269","article-title":"Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy","volume":"19","author":"Kuo","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijsu.2017.07.071","article-title":"Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment","volume":"45","author":"Wang","year":"2017","journal-title":"Int J Surg"},{"key":"48","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/jjco\/hyx038","article-title":"A Phase I\/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma","volume":"47","author":"Arai","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"49","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.3748\/wjg.v18.i39.5542","article-title":"Dietary copper triggers onset of fulminant hepatitis in the Long-Evans cinnamon rat model","volume":"18","author":"Schmidt","year":"2012","journal-title":"World J Gastroenterol"},{"key":"50","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1681\/ASN.V1171216","article-title":"The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation","volume":"11","author":"Schlatter","year":"2000","journal-title":"J Am Soc Nephrol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T08:46:30Z","timestamp":1660121190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,12]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1,2]]}},"alternative-id":["23142","29416650"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.23142","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,12]]}}}